Jump to ContentJump to Main Navigation
The Genealogy of a GenePatents, HIV/AIDS, and Race$
Users without a subscription are not able to see the full content.

Myles W. Jackson

Print publication date: 2015

Print ISBN-13: 9780262028660

Published to MIT Press Scholarship Online: September 2015

DOI: 10.7551/mitpress/9780262028660.001.0001

Show Summary Details
Page of

PRINTED FROM MIT PRESS SCHOLARSHIP ONLINE (www.mitpress.universitypressscholarship.com). (c) Copyright The MIT Press, 2022. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in MITSO for personal use.date: 06 July 2022

CCR5 and HIV/AIDS Diagnostics and Therapeutics

CCR5 and HIV/AIDS Diagnostics and Therapeutics

(p.103) 6 CCR5 and HIV/AIDS Diagnostics and Therapeutics
The Genealogy of a Gene

Myles W. Jackson

The MIT Press

In the last years of the 20th century, the CCR5 gene and its protein product became the objects of state-of-the-art work on diagnostics and drug treatment. The CCR5 patent’s lineage is now the subject of biomedical research on chemokine receptors and is entangled in the complex political, social, and biomedical lineages of HIV/AIDS with Big Pharma playing the lead role. The gene’s genealogy has been humanized and inextricably linked to the lives of the tens of millions infected worldwide. Once again, intellectual property issues resurface. HIV/AIDS diagnostic tests and medications have been patented by Big and Small Pharma alike, and the ramifications of those patents have been felt worldwide, including India, where attempts are underway to create generic drugs, which bind to the HIV-co-receptor.

Keywords:   Big Pharma, HIV/AIDS, intellectual property, compulsory licensing, Pfizer, GlaxoSmithKline, Maraviroc, Selzentry

MIT Press Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.